These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 33042163)

  • 21. Interaction between the gut microbiome and mucosal immune system.
    Shi N; Li N; Duan X; Niu H
    Mil Med Res; 2017; 4():14. PubMed ID: 28465831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut microbiome and cancer immunotherapy.
    Li W; Deng Y; Chu Q; Zhang P
    Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A gut feeling: Microbiome-brain-immune interactions modulate social and affective behaviors.
    Sylvia KE; Demas GE
    Horm Behav; 2018 Mar; 99():41-49. PubMed ID: 29427583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nutritional Modulation of the Microbiome and Immune Response.
    Burr AHP; Bhattacharjee A; Hand TW
    J Immunol; 2020 Sep; 205(6):1479-1487. PubMed ID: 32900885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feed, Microbiota, and Gut Immunity: Using the Zebrafish Model to Understand Fish Health.
    López Nadal A; Ikeda-Ohtsubo W; Sipkema D; Peggs D; McGurk C; Forlenza M; Wiegertjes GF; Brugman S
    Front Immunol; 2020; 11():114. PubMed ID: 32117265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host-Gut Microbiota Interactions during Inflammatory Bowel Disease.
    Leber A; Hontecillas R; Tubau-Juni N; Zoccoli-Rodriguez V; Abedi V; Bassaganya-Riera J
    Front Immunol; 2018; 9():363. PubMed ID: 29535731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D signaling in intestinal innate immunity and homeostasis.
    Dimitrov V; White JH
    Mol Cell Endocrinol; 2017 Sep; 453():68-78. PubMed ID: 28412519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal barrier and gut microbiota: Shaping our immune responses throughout life.
    Takiishi T; Fenero CIM; Câmara NOS
    Tissue Barriers; 2017 Oct; 5(4):e1373208. PubMed ID: 28956703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Intestinal Virome and Immunity.
    Neil JA; Cadwell K
    J Immunol; 2018 Sep; 201(6):1615-1624. PubMed ID: 30181300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut microbiome in multiple sclerosis: The players involved and the roles they play.
    Shahi SK; Freedman SN; Mangalam AK
    Gut Microbes; 2017 Nov; 8(6):607-615. PubMed ID: 28696139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiota and hematopoietic stem cell transplantation: where do we stand?
    Zama D; Biagi E; Masetti R; Gasperini P; Prete A; Candela M; Brigidi P; Pession A
    Bone Marrow Transplant; 2017 Jan; 52(1):7-14. PubMed ID: 27348539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of Formation, Physicochemical Properties, and Digestion of Ovotransferrin Nanofibrils with Covalent or Non-Covalent Bound Gallic Acid.
    Wei Z; Huang Q
    J Agric Food Chem; 2019 Sep; 67(35):9907-9915. PubMed ID: 31436102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Microbiotic Highway to Health-New Perspective on Food Structure, Gut Microbiota, and Host Inflammation.
    Hansen NW; Sams A
    Nutrients; 2018 Oct; 10(11):. PubMed ID: 30380701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 1 Interferon in the Human Intestine-A Co-ordinator of the Immune Response to the Microbiota.
    Giles EM; Stagg AJ
    Inflamm Bowel Dis; 2017 Apr; 23(4):524-533. PubMed ID: 28296819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biodegradable and biocompatible spherical dendrimer nanoparticles with a gallic acid shell and a double-acting strong antioxidant activity as potential device to fight diseases from "oxidative stress".
    Alfei S; Catena S; Turrini F
    Drug Deliv Transl Res; 2020 Feb; 10(1):259-270. PubMed ID: 31628606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crosstalk Between The Immune Receptors and Gut Microbiota.
    Mu C; Yang Y; Zhu W
    Curr Protein Pept Sci; 2015; 16(7):622-31. PubMed ID: 26122782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probing Gallic Acid for Its Broad Spectrum Applications.
    Choubey S; Goyal S; Varughese LR; Kumar V; Sharma AK; Beniwal V
    Mini Rev Med Chem; 2018; 18(15):1283-1293. PubMed ID: 29600764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome.
    Camara-Lemarroy CR; Metz LM; Yong VW
    World J Gastroenterol; 2018 Oct; 24(37):4217-4223. PubMed ID: 30310254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Formation of Glycan-Specific Natural Antibodies Repertoire in GalT-KO Mice Is Determined by Gut Microbiota.
    Bello-Gil D; Audebert C; Olivera-Ardid S; Pérez-Cruz M; Even G; Khasbiullina N; Gantois N; Shilova N; Merlin S; Costa C; Bovin N; Mañez R
    Front Immunol; 2019; 10():342. PubMed ID: 30891034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.